Imagine one of Denmark's many picturesque beaches, the waves lapping against the shore, the golden sand and the smooth ...

Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, published Jan. 29 in Nature Communications, reveals a new signaling mechanism ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Wong, Founder and CEO of HCW Biologics, commented, “The FDA’s clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step closer to advancing a potentially transformative ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.